The DOI matches its Crossref record; 289 of the 289 references it cites were found in a registry or an index.
Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment
Open accessAbstract
Exploiting the tumour microenvironment can benefit the design of nanomaterials for enhanced therapeutic effectiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–289 of 289
Mizuhara, T., Saha, K., Moyano, D. F., Kim, C. S., Yan, B., Kim, Y., & Rotello, V. M. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201411615 · Cited by 182
Yang, W., Liu, S., Bai, T., Keefe, A. J., Zhang, L., Ella-Menye, J.-R., Li, Y., & Jiang, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.02.004 · Cited by 181
Parodi, A., Haddix, S. G., Taghipour, N., Scaria, S., Taraballi, F., Cevenini, A., Yazdi, I. K., Corbo, C., Palomba, R., Khaled, S. Z., et al. (2014) · ACS Nano · doi:10.1021/nn502807n · Cited by 181
Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
Backer, M. V., Gaynutdinov, T. I., Patel, V., Bandyopadhyaya, A. K., Thirumamagal, B. T. S., Tjarks, W., Barth, R. F., Claffey, K., & Backer, J. M. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0161 · Cited by 180
In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine
Chen, F., Hong, H., Goel, S., Graves, S. A., Orbay, H., Ehlerding, E. B., Shi, S., Theuer, C. P., Nickles, R. J., & Cai, W. (2015) · ACS Nano · doi:10.1021/nn507241v · Cited by 175
Zhao, Y., Luo, Z., Li, M., Qu, Q., Ma, X., Yu, S., & Zhao, Y. (2015) · Angewandte Chemie · doi:10.1002/ange.201408510 · Cited by 173
Kadowaki, N., Antonenko, S., Ho, S., Rissoan, M.-C., Soumelis, V., Porcelli, S. A., Lanier, L. L., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.10.1221 · Cited by 172
The application of mesoporous silica nanoparticle family in cancer theranostics
Feng, Y., Panwar, N., Tng, D. J. H., Tjin, S. C., Wang, K., & Yong, K.-T. (2016) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2016.04.019 · Cited by 171
Tumour-associated macrophages and cancer
Cook, J., & Hagemann, T. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.017 · Cited by 165
Targeting Vascular Pericytes in Hypoxic Tumors Increases Lung Metastasis via Angiopoietin-2
Keskin, D., Kim, J., Cooke, V. G., Wu, C.-C., Sugimoto, H., Gu, C., De Palma, M., Kalluri, R., & LeBleu, V. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.035 · Cited by 165
Facile Generation of Tumor‐pH‐Labile Linkage‐Bridged Block Copolymers for Chemotherapeutic Delivery
Sun, C., Liu, Y., Du, J., Cao, Z., Xu, C., & Wang, J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509507 · Cited by 165
Self-citationEngineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics
Nguyen, K. T., & Zhao, Y. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00316 · Cited by 165
Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets
Nagy, J. A., & Dvorak, H. F. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9500-6 · Cited by 163
Monodispersed calcium carbonate nanoparticles modulate local pH and inhibit tumor growth in vivo
Som, A., Raliya, R., Tian, L., Akers, W., Ippolito, J. E., Singamaneni, S., Biswas, P., & Achilefu, S. (2016) · Nanoscale · doi:10.1039/c5nr06162h · Cited by 162
Self-Monitoring Artificial Red Cells with Sufficient Oxygen Supply for Enhanced Photodynamic Therapy
Luo, Z., Zheng, M., Zhao, P., Chen, Z., Siu, F., Gong, P., Gao, G., Sheng, Z., Zheng, C., Ma, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep23393 · Cited by 159
Qian, Y., Jin, H., Qiao, S., Dai, Y., Huang, C., Lu, L., Luo, Q., & Zhang, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.008 · Cited by 159
Self-citationVCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo
Gosk, S., Moos, T., Gottstein, C., & Bendas, G. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.12.021 · Cited by 158
Liu, Y., Zhang, D., Qiao, Z., Qi, G., Liang, X., Chen, X., & Wang, H. (2015) · Advanced Materials · doi:10.1002/adma.201501502 · Cited by 157
Self-citationpHLIP peptide targets nanogold particles to tumors
Yao, L., Daniels, J., Moshnikova, A., Kuznetsov, S., Ahmed, A., Engelman, D. M., Reshetnyak, Y. K., & Andreev, O. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219665110 · Cited by 156
Enhancing Photodynamic Therapy Efficacy by Using Fluorinated Nanoplatform
Que, Y., Liu, Y., Tan, W., Feng, C., Shi, P., Li, Y., & Huang, X. (2016) · ACS Macro Letters · doi:10.1021/acsmacrolett.5b00935 · Cited by 155
Ansari, C., Tikhomirov, G. A., Hong, S. H., Falconer, R. A., Loadman, P. M., Gill, J. H., Castaneda, R., Hazard, F. K., Tong, L., Lenkov, O. D., et al. (2013) · Small · doi:10.1002/smll.201301456 · Cited by 154
Touqui, L., & Alaoui-El-Azher, M. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363258 · Cited by 151
Dumitru, C. A., Gholaman, H., Trellakis, S., Bruderek, K., Dominas, N., Gu, X., Bánkfalvi, Á., Whiteside, T. L., Lang, S., & Brandau, S. (2011) · International Journal of Cancer · doi:10.1002/ijc.25991 · Cited by 146
VEGF121-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System
Goel, S., Chen, F., Hong, H., Valdovinos, H. F., Hernandez, R. T., Shi, S., Barnhart, T. E., & Cai, W. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am506849p · Cited by 136
Nanomedicine : A Great First Year And, with Your Help, A Bright Future Ahead
Martin, C. R. (2007) · Nanomedicine · doi:10.2217/17435889.2.3.265 · Cited by 130
Drug delivery to macrophages: Challenges and opportunities
Pei, Y., & Yeo, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.014 · Cited by 129
Extracellular Matrix of Ovarian Tumors
Ricciardelli, C., & Rodgers, R. J. (2006) · Seminars in Reproductive Medicine · doi:10.1055/s-2006-948556 · Cited by 128
Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis
Doolittle, E., Peiris, P. M., Doron, G., Goldberg, A. L., Tucci, S. T., Rao, S. P., Shah, S., Sylvestre, M., Govender, P., Turan, O., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b01552 · Cited by 125
Hu, J., Miura, S., Na, K., & Bae, Y. H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.007 · Cited by 123
Pittella, F., Miyata, K., Maeda, Y., Suma, T., Watanabe, S. T., Chen, Q., Christie, R. J., Osada, K., Nishiyama, N., & Kataoka, K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.005 · Cited by 120
Heterogeneity of tumor endothelial cells and drug delivery
Hida, K., Maishi, N., Sakurai, Y., Hida, Y., & Harashima, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.008 · Cited by 120
Molecular targeting of liposomal nanoparticles to tumor microenvironment
Zhao, G., & Rodriguez, L. B. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s37859 · Cited by 119
Applications of Nitroimidazole In Vivo Hypoxia Imaging in Ischemic Stroke
Takasawa, M., Moustafa, R. R., & Baron, J. (2008) · Stroke · doi:10.1161/strokeaha.107.485938 · Cited by 118
VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor
Abakumov, M. A., Nukolova, N. V., Sokolsky‐Papkov, M., Shein, S. A., Sandalova, T., Vishwasrao, H. M., Grinenko, N. F., Gubskiy, I. L., Abakumov, A. M., Kabanov, A. V., et al. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.12.011 · Cited by 116
Alshamsan, A., Hamdy, S. I., Samuel, J., El‐Kadi, A. O. S., Lavasanifar, A., & Uludağ, H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.003 · Cited by 114
Proteases in cancer drug delivery
Vandooren, J., Opdenakker, G., Loadman, P. M., & Edwards, D. R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.020 · Cited by 114
Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability
Palomba, R., Parodi, A., Evangelopoulos, M., Acciardo, S., Corbo, C., Rosa, E. D., Yazdi, I. K., Scaria, S., Molinaro, R., Furman, N. E. T., et al. (2016) · Scientific Reports · doi:10.1038/srep34422 · Cited by 114
Zwitterionic polymer-protein conjugates reduce polymer-specific antibody response
Liu, S., & Jiang, S. (2016) · Nano Today · doi:10.1016/j.nantod.2016.05.006 · Cited by 112
Cun, X., Chen, J., Ruan, S., Zhang, L., Wan, J., He, Q., & Gao, H. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b09391 · Cited by 109
Engineered materials for cancer immunotherapy
Cheung, A. S., & Mooney, D. J. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.007 · Cited by 108
Nicotinamide can lower tumor interstitial fluid pressure: mechanistic and therapeutic implications.
Lee, I., Boucher, Y., & Jain, R. K. (1992) · PubMed · Cited by 105
Nosoudi, N., Nahar-Gohad, P., Sinha, A., Chowdhury, A., Gerard, P., Carsten, C. G., Gray, B. H., & Vyavahare, N. R. (2015) · Circulation Research · doi:10.1161/circresaha.115.307207 · Cited by 103
Sundaram, H. S., Ella‐Menye, J., Brault, N. D., Shao, Q., & Jiang, S. (2013) · Chemical Science · doi:10.1039/c3sc52233d · Cited by 101
Hypoxia-Activated Prodrugs in Cancer Therapy: Progress to the Clinic
Denny, W. A. (2010) · Future Oncology · doi:10.2217/fon.10.1 · Cited by 100
Mesenchymal stem cell signaling in cancer progression
Torsvik, A., & Bjerkvig, R. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.03.005 · Cited by 100
Slomiany, M. G., Dai, L., Bomar, P. A., Knackstedt, T., Kranc, D. A., Tolliver, L. B., Maria, B. L., & Toole, B. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0143 · Cited by 99
Cao, H., Zhang, Z., Zhao, S., He, X., Yu, H., Yin, Q., Zhang, Z., Gu, W., Chen, L., & Li, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.015 · Cited by 95
Newer nanoparticles in hyperthermia treatment and thermometry
Sharma, R. D., & J.Chen, C. (2008) · Journal of Nanoparticle Research · doi:10.1007/s11051-008-9548-z · Cited by 95
Hybrid Collagenase Nanocapsules for Enhanced Nanocarrier Penetration in Tumoral Tissues
Villegas, M. R., Baeza, A., & Vallet‐Regí, M. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b07116 · Cited by 95
Tang, S., Meng, Q., Sun, H., Su, J., Yin, Q., Zhang, Z., Yu, H., Chen, L., Chen, Y., Gu, W., et al. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201601703 · Cited by 94
Nanoparticle therapeutics: Technologies and methods for overcoming cancer
Cerqueira, B. B. S., Lasham, A., Shelling, A. N., & Al‐Kassas, R. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.10.007 · Cited by 93
pHLIP®-mediated delivery of PEGylated liposomes to cancer cells
Yao, L., Daniels, J., Wijesinghe, D., Andreev, O. A., & Reshetnyak, Y. K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.037 · Cited by 93
Yoshimoto, K., Hirase, T., Madsen, J., Armes, S. P., & Nagasaki, Y. (2009) · Macromolecular Rapid Communications · doi:10.1002/marc.200900484 · Cited by 92
Myeloid‐Derived Suppressor Cells and Therapeutic Strategies in Cancer
Katoh, H., & Watanabe, M. (2015) · Mediators of Inflammation · doi:10.1155/2015/159269 · Cited by 91
Kuhn, S., Finch, S. K., Hallahan, D. E., & Giorgio, T. D. (2006) · Nano Letters · doi:10.1021/nl052241g · Cited by 88
B cells and their mediators as targets for therapy in solid tumors
Gunderson, A. J., & Coussens, L. M. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.005 · Cited by 82
Strategies for triggered drug release from tumor targeted liposomes
Blenke, E. O., Mastrobattista, E., & Schiffelers, R. M. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.805742 · Cited by 80
Feng, W., Gao, X. Y., McClung, G., Zhu, S., Ishihara, K., & Brash, J. L. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.06.007 · Cited by 79
Jin, Q., Xu, J., Ji, J., et al. (2008) · Chemical Communications · doi:10.1039/b801959b · Cited by 77
Heterogeneity of tumor endothelial cells
Hida, K., Ohga, N., Akiyama, K., Maishi, N., & Hida, Y. (2013) · Cancer Science · doi:10.1111/cas.12251 · Cited by 76
Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft.
Kristjansen, P. E. G., Boucher, Y., & Jain, R. K. (1993) · PubMed · Cited by 76
Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models
Lu, C., Shahzad, M. M. K., Moreno‐Smith, M., Lin, Y. G., Jennings, N. B., Allen, J. K., Landen, C. N., Mangala, L. S., Armaiz-Peña, G. N., Schmandt, R. E., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.3.10635 · Cited by 75
Lotz, C., Kelleher, D. K., Gaßner, B., Gekle, M., Vaupel, P. W., & Thews, O. (2007) · Oncology Reports · doi:10.3892/or.17.1.239 · Cited by 74
Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment
Dewitte, H., Verbeke, R., Breckpot, K., Smedt, S. C. D., & Lentacker, I. (2014) · Nano Today · doi:10.1016/j.nantod.2014.10.001 · Cited by 72
Grünwald, B. T., Vandooren, J., Locatelli, E., Fiten, P., Opdenakker, G., Proost, P., Krüger, A., Lellouche, J., Israel, L. L., Shenkman, L., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.08.016 · Cited by 69
Yang, C., Liu, Y., He, Y., Du, Y., Wang, W., Shi, X., & Gao, F. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.036 · Cited by 68
Cancer Targeted Drug Delivery: An Elusive Dream
(2013) · doi:10.1007/978-1-4614-7876-8 · Cited by 67
Lee, K. L., Albee, K., Bernasconi, R., et al. (1997) · Biochemical Journal · doi:10.1042/bj3270199 · Cited by 66
Liao, D., Liu, Z., Wrasidlo, W., Luo, Y., Nguyen, G., Chen, T., Xiang, R., & Reisfeld, R. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1264 · Cited by 64
Kuriyama, N., Kuriyama, H., Julin, C. M., et al. (2001) · PubMed · Cited by 59
Extracellular matrix, biotensegrity and tumor microenvironment. An update and overview.
Noguera, R., Nieto, O. A., Tadeo, I., Fariñas, F., & Álvaro, T. (2012) · PubMed · doi:10.14670/hh-27.693 · Cited by 57
Methods in pharmacology and toxicology
Housley, G. D. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01930-1 · Cited by 56
Lammerts, E., Roswall, P., Sundberg, C., Gotwals, P. J., Koteliansky, V., Reed, R. K., Heldin, N., & Rubin, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10722 · Cited by 55
Hypoxia-Sensitive Materials for Biomedical Applications
Yu, J., Zhang, Y., Hu, X., Wright, G., & Gu, Z. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-016-1578-6 · Cited by 50
Transformable DNA nanocarriers for plasma membrane targeted delivery of cytokine
Sun, W., Ji, W., Hu, Q., Yu, J., Wang, C., Qian, C., Hochu, G. M., & Gu, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.011 · Cited by 50
Development of hypoxia-triggered prodrug micelles as doxorubicin carriers for tumor therapy
Liu, H., Zhang, R., Niu, Y., Li, Y., Qiao, C.-M., Weng, J., Li, J., Zhang, X., Xiao, Z., & Zhang, X. (2015) · RSC Advances · doi:10.1039/c4ra14875d · Cited by 48
pH‐Controlled Delivery of Nanoparticles into Tumor Cells
Han, L., Ma, H., Guo, Y., Kuang, Y., He, X., & Jiang, C. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300013 · Cited by 44
Transcriptional dissection of pancreatic tumors engrafted in mice
Martinez-Garcia, R., Juan, D., Rausell, A., Muñoz, M., Baños, N., Menéndez, C., Lopez-Casas, P. P., Rico, D., Valencia, A., & Hidalgo, M. M. (2014) · Genome Medicine · doi:10.1186/gm544 · Cited by 43
Zhao, P., Zheng, M., Luo, Z., Fan, X., Sheng, Z., Gong, P., Chen, Z., Zhang, B., Ni, D., Ma, Y., et al. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600121 · Cited by 43
Emerich, D. F., Dean, R. L., Snodgrass, P., Lafreniere, D., Agostino, M., Wiens, T., Xiong, H., Hasler, B. P., Marsh, J. P., Pink, M. M., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38780-4 · Cited by 42
Hypoxia-responsive drug–drug conjugated nanoparticles for breast cancer synergistic therapy
Zhang, R., Li, Y., Zhang, M., Tang, Q., & Zhang, X. (2016) · RSC Advances · doi:10.1039/c6ra01560c · Cited by 39
He, X., Yu, H., Bao, X., Cao, H., Yin, Q., Zhang, Z., & Li, Y. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500626 · Cited by 38
Makino, J., Cabral, H., Miura, Y., Matsumoto, Y., Wang, M., Kinoh, H., Mochida, Y., Nishiyama, N., & Kataoka, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.017 · Cited by 34
Kim, H. L., Lee, S. B., Jeong, H. J., & Kim, D. W. (2014) · RSC Advances · doi:10.1039/c4ra03905j · Cited by 32
Liu, J., Liu, Q., Yang, C., Sun, Y., Zhang, Y., Huang, P., Zhou, J., Liu, Q., Chu, L., Huang, F., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b01501 · Cited by 24
Drug Shortages and the Burden of Access to Care: A Critical Issue Affecting Patients With Cancer
McKeever, A. E., Bloch, J. R., & Bratic, A. (2013) · Clinical journal of oncology nursing · doi:10.1188/13.cjon.490-495 · Cited by 23
Patel, N., Duffy, B. A., Badar, A., Lythgoe, M. F., & Årstad, E. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00380 · Cited by 23
Zeng, Y., Zhang, S., Jia, M., Liu, Y., Shang, J., Guo, Y., Xu, J., & Wu, D. (2013) · Nanoscale · doi:10.1039/c3nr04349e · Cited by 20
Liang, X., & Wang, M. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9893-8 · Cited by 9
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Biomedicine Meets Fenton Chemistry
Tang, Z., Zhao, P., Wang, H., Liu, Y., & Bu, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00977 · Cited by 745
Liu, C., Wang, D., Zhang, S., Cheng, Y., Yang, F., Xing, Y., Xu, T., Dong, H., & Zhang, X. (2019) · ACS Nano · doi:10.1021/acsnano.8b09387 · Cited by 641
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
Du, R., Huang, C., Liu, K., Li, X., & Dong, Z. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01305-3 · Cited by 586
Jiang, Y., Li, J., Zhen, X., Xie, C., & Pu, K. (2018) · Advanced Materials · doi:10.1002/adma.201705980 · Cited by 601
Metadata
- Authors
- Dai, Y., Xu, C., Sun, X., & Chen, X.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2017
- Volume
- 46
- Issue
- 12
- Pages
- 3830-3852
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2615993918
- Cited by
- 931
- References
- 289
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.